453 related articles for article (PubMed ID: 36515657)
21. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
22. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
23. Ovine recombinant PrP as an inhibitor of ruminant prion propagation in vitro.
Workman RG; Maddison BC; Gough KC
Prion; 2017 Jul; 11(4):265-276. PubMed ID: 28665745
[TBL] [Abstract][Full Text] [Related]
24. Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies.
Martucci F; Acutis P; Mazza M; Nodari S; Colussi S; Corona C; Barocci S; Gabrielli A; Caramelli M; Casalone C; Moroncini G
J Gen Virol; 2009 Apr; 90(Pt 4):1048-1053. PubMed ID: 19223486
[TBL] [Abstract][Full Text] [Related]
25. PrP knock-out and PrP transgenic mice in prion research.
Weissmann C; Flechsig E
Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
27. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
28. Prion protein oligomer and its neurotoxicity.
Huang P; Lian F; Wen Y; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
[TBL] [Abstract][Full Text] [Related]
29. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
30. Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).
McCarthy JM; Franke M; Resenberger UK; Waldron S; Simpson JC; Tatzelt J; Appelhans D; Rogers MS
PLoS One; 2013; 8(1):e55282. PubMed ID: 23383136
[TBL] [Abstract][Full Text] [Related]
31. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
[TBL] [Abstract][Full Text] [Related]
32. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
33. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
34. Prion disease: a deadly disease for protein misfolding.
Chakraborty C; Nandi S; Jana S
Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
[TBL] [Abstract][Full Text] [Related]
35. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
36. Molecular approaches to mechanisms of prion diseases.
Bratosiewicz-Wasik J; Wasik TJ; Liberski PP
Folia Neuropathol; 2004; 42 Suppl A():33-46. PubMed ID: 15449458
[TBL] [Abstract][Full Text] [Related]
37. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
38. Prion protein and scrapie susceptibility.
Smits MA; Bossers A; Schreuder BE
Vet Q; 1997 Sep; 19(3):101-5. PubMed ID: 9323849
[TBL] [Abstract][Full Text] [Related]
39. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
40. [Prion diseases or transmissible spongiform encephalopathies].
Brandel JP
Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
